| Basic Information | |
|---|---|
| Species | Glycine max |
| Cazyme ID | Glyma13g23040.2 |
| Family | GT47 |
| Protein Properties | Length: 469 Molecular Weight: 54196.3 Isoelectric Point: 9.6036 |
| Chromosome | Chromosome/Scaffold: 13 Start: 26502178 End: 26505084 |
| Description | Exostosin family protein |
| View CDS | |
| External Links |
|---|
| NCBI Taxonomy |
| Plaza |
| CAZyDB |
| Signature Domain Download full data set without filtering | |||
|---|---|---|---|
| Family | Start | End | Evalue |
| GT47 | 131 | 417 | 0 |
| KRFKVWVYEEGDQPLVHYGPVNDIYAIEGQFIDEMDNSKRSPFKAKNPDEAHAFFLPFSVVNVVHYAYKPYMSQNDYRRDRLQRLVEDYIVVVADKYPYW NRSNGADHFLLSCHDWAPEISHANPDLFKNFIRVLCNANNSEGFQPKRDVSIPEVYLSVGKLGPPNLGQHPMNRTILAFFSGGAHGDIRKLLLKHWKDKD NQVQVHEYLPKGQNYTELMGLSKFCLCPSGYEVASPRVVEAINAVCVPVIISENYSLPLSDVLNWSQFSIQISVENIPDIKTILQNV | |||
| Full Sequence |
|---|
| Protein Sequence Length: 469 Download |
| MLSSRCSTAS MLLPLLFPIF LFLFIIHLEG NHLSFEFPNF SLSSIKGITT QLQPHGQYLA 60 NSAYRSLEHR IKKRTSFDVV EEGLAKARAS IREAILSRNH SNSGKQEDFI PKGSIYRNPH 120 AFHQSHIEMV KRFKVWVYEE GDQPLVHYGP VNDIYAIEGQ FIDEMDNSKR SPFKAKNPDE 180 AHAFFLPFSV VNVVHYAYKP YMSQNDYRRD RLQRLVEDYI VVVADKYPYW NRSNGADHFL 240 LSCHDWAPEI SHANPDLFKN FIRVLCNANN SEGFQPKRDV SIPEVYLSVG KLGPPNLGQH 300 PMNRTILAFF SGGAHGDIRK LLLKHWKDKD NQVQVHEYLP KGQNYTELMG LSKFCLCPSG 360 YEVASPRVVE AINAVCVPVI ISENYSLPLS DVLNWSQFSI QISVENIPDI KTILQNVTQK 420 KYKKLYRNVR RVRRHFVMHR PAKPFDLMHM IIHSIWLRRL NFRLMASH* 480 |
| Functional Domains Download unfiltered results here | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
| pfam03016 | Exostosin | 2.0e-64 | 129 | 417 | 307 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. | ||
| Gene Ontology | |
|---|---|
| GO Term | Description |
| GO:0016020 | membrane |
| Annotations - NR Download unfiltered results here | |||||||
|---|---|---|---|---|---|---|---|
| Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
| GenBank | ABP03872.1 | 0 | 72 | 464 | 74 | 465 | Exostosin-like [Medicago truncatula] |
| GenBank | ABP03873.1 | 0 | 41 | 467 | 193 | 616 | Exostosin-like [Medicago truncatula] |
| EMBL | CBI21065.1 | 0 | 70 | 464 | 8 | 400 | unnamed protein product [Vitis vinifera] |
| EMBL | CBI25537.1 | 0 | 71 | 464 | 82 | 475 | unnamed protein product [Vitis vinifera] |
| RefSeq | XP_002263848.1 | 0 | 71 | 464 | 1 | 394 | PREDICTED: hypothetical protein [Vitis vinifera] |
| Metabolic Pathways | |||
|---|---|---|---|
| Pathway Name | Reaction | EC | Protein Name |
| xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |
